Receiving more than one updated booster is not currently authorized by the FDA, according to the CDC. U.S. health officials are reportedly trying to move the nation toward an annual booster aimed at reducing the severity of the disease rather than prevention. Recent studies showed the protection provided by the bivalent booster shot decreased after a few months, but health officials say there’s not enough data to justify rolling out another round of shots.
“The bottom line is that there is some waning of protection for those who got boosters more than six months ago and haven’t had an intervening infection,” Bob Wachter, MD, UCSF’s chair of medicine, told the Chronicle. “But the level of protection versus severe infection continues to be fairly high, good enough that people who aren’t at super high risk are probably fine waiting until a new booster comes out in the fall.”
Only 16.4 percent of those eligible to receive the latest booster have, according to the report.
On March 28, the World Health Organization also updated its COVID-19 vaccination guidelines, recommending booster shots for older and high-risk groups, but suggesting healthy children and adolescents may not need the shot.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
